Kestra Medical Technologies, Ltd.
KMTS
$24.24
-$0.75-3.00%
NASDAQ
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.78% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.78% | 0.00% | |||
| Cost of Revenue | -2.15% | 0.00% | |||
| Gross Profit | 30.55% | 0.00% | |||
| SG&A Expenses | 16.98% | 0.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.72% | 0.00% | |||
| Operating Income | -9.68% | 0.00% | |||
| Income Before Tax | -6.24% | 0.00% | |||
| Income Tax Expenses | 140.00% | 0.00% | |||
| Earnings from Continuing Operations | -6.29% | 0.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -27.75% | 0.00% | |||
| Net Income | -6.87% | 0.00% | |||
| EBIT | -9.68% | 0.00% | |||
| EBITDA | -12.32% | 0.00% | |||
| EPS Basic | 99.42% | 0.00% | |||
| Normalized Basic EPS | 99.43% | 0.00% | |||
| EPS Diluted | 99.42% | 0.00% | |||
| Normalized Diluted EPS | 99.43% | 0.00% | |||
| Average Basic Shares Outstanding | 18,695.27% | 0.00% | |||
| Average Diluted Shares Outstanding | 18,695.27% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||